In vitro and in vivo evaluation of the subtype-selective muscarinic agonist PD 151832
- 1 February 1995
- journal article
- Published by Elsevier in Life Sciences
- Vol. 56 (11-12) , 845-852
- https://doi.org/10.1016/0024-3205(95)00019-3
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Synthesis and Sar of bulky 1-azabicyclo[2.2.1]-3-one oximes as muscarinic receptor subtype selective agonistsLife Sciences, 1993
- A rationale for the design and synthesis of m1 selective muscarinic agonists.Bioorganic & Medicinal Chemistry Letters, 1992
- Cholinomimetics and Alzheimer's diseaseBioorganic & Medicinal Chemistry Letters, 1992
- Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodiesJournal of Neuroscience, 1991
- Effects of acute infusion of the muscarinic cholinergic agonist arecoline on verbal memory and visuo-spatial function in dementia of the alzheimer typeProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1991
- No response to high‐dose muscarinic agonist therapy in Alzheimer's diseaseNeurology, 1988
- Effects of Cholinergic Enhancement Therapies on Memory Function in Alzheimer's Disease: A Meta-Analysis of the LiteratureAustralian & New Zealand Journal of Psychiatry, 1986
- Loss of M2 Muscarine Receptors in the Cerebral Cortex in Alzheimer's Disease and Experimental Cholinergic DenervationScience, 1985
- Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal ForebrainScience, 1982
- SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASEPublished by Elsevier ,1976